Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Infinium Pharmachem's Enterprise Value is ₹3,606 Mil.
Infinium Pharmachem's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹206 Mil. Therefore, Infinium Pharmachem's EV-to-EBIT ratio for today is 17.47.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Infinium Pharmachem's Enterprise Value is ₹3,606 Mil.
Infinium Pharmachem's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹237 Mil. Therefore, Infinium Pharmachem's EV-to-EBITDA ratio for today is 15.21.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Infinium Pharmachem's Enterprise Value is ₹3,606 Mil.
Infinium Pharmachem's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1,896 Mil. Therefore, Infinium Pharmachem's EV-to-Revenue ratio for today is 1.90.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Infinium Pharmachem (NSE:INFINIUM) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Infinium Pharmachem's current Enterprise Value is ₹3,606 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Infinium Pharmachem's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹206 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Infinium Pharmachem's current Enterprise Value is ₹3,606 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Infinium Pharmachem's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹237 Mil.
Infinium Pharmachem's current Enterprise Value is ₹3,606 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Infinium Pharmachem's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1,896 Mil.
Infinium Pharmachem's current Enterprise Value is ₹3,606 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Infinium Pharmachem's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ₹337 Mil.
Infinium Pharmachem's current Enterprise Value is ₹3,606 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Infinium Pharmachem's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹240 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Infinium Pharmachem Enterprise Value Related Terms
Infinium Pharmachem Enterprise Value Historical Data
* Premium members only.
The historical data trend for Infinium Pharmachem's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Infinium Pharmachem's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Infinium Pharmachem Enterprise Value vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Infinium Pharmachem's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Infinium Pharmachem's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Infinium Pharmachem's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Infinium Pharmachem (NSE:INFINIUM) has a Enterprise Value of ₹3,606 Mil as of Jul. 09, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Infinium Pharmachem and its competitors.
Is Infinium Pharmachem's Enterprise Value too high?
Infinium Pharmachem's current Enterprise Value is ₹3,606 Mil. Overall, Infinium Pharmachem has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Infinium Pharmachem's Enterprise Value compare to DOW?
Infinium Pharmachem's Enterprise Value of ₹3,606 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Chemicals company?
A good Enterprise Value depends on the Chemicals industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Infinium Pharmachem and its competitors. Infinium Pharmachem's current Enterprise Value is ₹3,606 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Infinium Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Infinium Pharmachem (NSE:INFINIUM) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹304.35, compared to a current price of ₹212.25 — trading 30.3% below its estimated fair value. The current Enterprise Value is ₹3,606 Mil. Infinium Pharmachem's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Infinium Pharmachem (NSE:INFINIUM), the current Enterprise Value is ₹3,606 Mil as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Infinium Pharmachem (NSE:INFINIUM) Overvalued in 2026?
Based on GuruFocus' analysis, Infinium Pharmachem stock appears to be undervalued.
The current stock price of ₹212.25 is trading 30.3% below its estimated GF Value™ of ₹304.35.
GuruFocus considers Infinium Pharmachem to be Significantly Undervalued.
Key valuation signals for NSE:INFINIUM:
Enterprise Value: ₹3,606 Mil
GF Value™: ₹304.35 vs. price of ₹212.25 (30.3% below fair value)
No single metric tells the full story. See the NSE:INFINIUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.
87GF Score
Get the complete analysis for NSE:INFINIUM
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INFINIUM has been successfully added to your 
